Research & Clinical Trials – Page 6
-
Research & Clinical TrialsA novel phase II clinical trial for malignant mesothelioma is expected to open soon and involve a versatile, biological drug already showing promise…
-
Research & Clinical Trials
University of Vermont Study Opens New Door for Mesothelioma Treatment
Researchers at the University of Vermont Cancer Center have uncovered a new approach to the treatment of malignant pleural mesothelioma, sparking a… -
Research & Clinical Trials
Study Supports Opdivo as Second-Line Mesothelioma Treatment
When the effectiveness of first-line chemotherapy fails and malignant mesothelioma returns, more patients could soon turn with confidence to a proven, second-line… -
Research & Clinical Trials
Researchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with… -
Research & Clinical Trials
New Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the… -
Research & Clinical Trials
Study Shows Access to Care Often Difficult for Mesothelioma Patients
When it comes to malignant pleural mesothelioma, not everyone is treated equally. A disparity in access to care makes the difference in… -
Research & Clinical Trials
Mesothelioma Research, COVID Findings Featured at IASLC Conference
Researchers from around the world presented their insights into serious lung health issues, including mesothelioma, during the International Association for the Study of… -
Research & Clinical Trials
Ramucirumab Shows Survival Benefits with Pleural Mesothelioma
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with… -
Research & Clinical Trials
Study: Pleural Mesothelioma Treatment Effective with Peritoneal Disease
The University of Texas MD Anderson Cancer Center has taken an immunotherapy treatment recently approved by the U.S. Food and Drug Administration… -
Research & Clinical Trials
Researchers Study New Immunotherapy Combination for Mesothelioma
The immunotherapy combination of tremelimumab and durvalumab has shown surprising efficacy, particularly as a second-line treatment option for patients with pleural…